book-Pharmacology and Vitreoretinal Surgery Developments in Ophthalmology B

book-Pharmacology and Vitreoretinal Surgery Developments in Ophthalmology B
book-Pharmacology and Vitreoretinal Surgery Developments in Ophthalmology B
book-Pharmacology and Vitreoretinal Surgery Developments in Ophthalmology B

book-download Pharmacology and Vitreoretinal Surgery Developments in Ophthalmology Bo




More than 35 years since the introduction of pars plana vitrectomy passed, and vitreoretinal has developed to advanced techniques to treat retinal diseases. Removing the vitreous gel and bleeding not only deletes the optical axis of the eye, but it allows the surgeon to approach the retina and vitreoretinal interface directly and thereby discharge traction and removal of pathological tissue such as epiretinal membranes. Removal of internal limiting membrane has proven to be a safe and effective technique in macular surgery, macular hole in cap. Twenty years ago nobody could have imagined. Today is definitely a success rate of more than 90% in the macula and reattachment surgery be achieved.
However, there are limitations of current vitreoretinal techniques based mechanically. Removal of the vitreous is incomplete, especially at the vitreous and retina-vitreous interface on the base. This can lead to persistent or recurrent traction on the retina in retinal tear formation or repro proliferation. More aggressive removal of the vitreous body by mechanical means, but carries the risk of damage to the retina. If epiretinal membranes in PVR cases removed, and in diabetic eyes with traction retinal detachment, gliotic scar tissue is removed, but neural retina is not treated. Thus, despite anatomic reattachment, visual results are often disappointing.

thx